Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Martinez, Maria Elena American Society Of Preventive Oncology, Inc. 2022 Annual Conference Grant: American Society of Preventive Oncology PA-21-151: NIH Support for Conferences and Scientific Meetings
Agarwal, Ashutosh University Of Miami School Of Medicine A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Counter, Christopher M Duke University Adapting K-MDS to detect KRAS-mutant ctDNA RFA-CA-21-003: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wong, David T University Of California Los Angeles Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients PAR-15-095: Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
Wei, Lei Roswell Park Cancer Institute Corp Advancing skin cancer prevention by tackling UV-induced clonogenic mutations PA-19-056: Research Project Grant
Lin, Jia-Ren Harvard Medical School Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images PAR-21-285: NCI Research Specialist (Laboratory-based Scientist) Award
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wang, Tza-Huei Jeff Johns Hopkins University A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies RFA-CA-21-004: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wolpin, Brian Matthew Dana-Farber Cancer Inst Altered metabolism and machine learning for pancreatic cancer early detection Pancreatic Cancer Detection Consortium PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units
Khush, Kiran Kaur Stanford University A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation PA-18-484: NIH Research Project Grant
Skubitz, Amy Patrice University Of Minnesota A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection PA-20-185: NIH Research Project Grant
Saenger, Yvonne Margaret Albert Einstein College Of Medicine Applying pathomics to establish a biosignature for aggressive skin melanoma Consortium for Imaging and Biomarkers PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Frazier, A Lindsay Dana-Farber Cancer Inst Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors PAR-18-317: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
Malmstadt, Noah University Of Southern California A Target-Directed Reagent Pipeline via Microfluidic mRNA Display Innovative Technology Development for Cancer Research RFA-CA-16-001: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Paulovich, Amanda G Fred Hutchinson Cancer Center A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer Early Detection Research Network RFA-CA-16-009: The Early Detection Research Network: Biomarker Developmental Laboratories

Pages